His weight was stable, and his mood had improved.
PET scan was negative for metastatic disease.
EXT: warm, well perfused  Pertinent Results: [**2164-3-7**] 04:12PM BLOOD WBC-14.3*# RBC-3.33* Hgb-11.1* Hct-31.4* MCV-94 MCH-33.2* MCHC-35.3* RDW-13.4 Plt Ct-203 [**2164-3-12**] 05:15AM BLOOD WBC-5.5 RBC-2.97* Hgb-9.8* Hct-27.8* MCV-93 MCH-33.0* MCHC-35.3* RDW-13.2 Plt Ct-213 [**2164-3-7**] 04:12PM BLOOD Glucose-172* UreaN-18 Creat-1.0 Na-141 K-4.0 Cl-106 HCO3-25 AnGap-14 [**2164-3-12**] 05:15AM BLOOD Glucose-102* UreaN-13 Creat-0.9 Na-139 K-3.2* Cl-106 HCO3-27 AnGap-9  [**2164-3-12**] UGI: IMPRESSION: No evidence of leak or obstruction.
After a brief, uneventful stay in the PACU, he was transferred to the ICU with an NGT, 1 chest tube, JP in neck, J-tube and Foley catheter.
Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored.
This was followed with serial CXRs, and resolved by [**2164-3-12**].
ID: His white blood count and fever curves were closely watched for signs of infection.
On [**2164-3-13**], patient began to have dysuria and UA was consistent with urinary tract infection.
Endocrine: His blood sugar was monitored throughout his stay; insulin dosing was adjusted accordingly.
Hematology: The patient's complete blood count was examined routinely; no transfusions were required.
Medications on Admission: ATENOLOL 25', COLCHICINE 0.6', LORAZEPAM 1mg Q6PRN, MOEXIPRIL 15', COLACE 100 UD, SENNA 2 UD  Discharge Medications: 1.
)(s)* Refills:*0* 6. docusate sodium 50 mg/5 mL Liquid Sig: Ten (10) ml PO BID (2 times a day).
Followup Instructions: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) **], MD Phone:[**Telephone/Fax (1) 2359**] Date/Time:[**2164-3-29**] 11:15 [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], RN Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2164-4-10**] 9:30 [**First Name8 (NamePattern2) 251**] [**Name8 (MD) **], MD Phone:[**0-0-**] Date/Time:[**2164-4-10**] 10:00
